Rocket Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Hello, everyone. Welcome to the morning session of Day 2 of the Bank of America Virtual Vegas Health Care Conference. I'm Greg Harrison, U.S. biopharma analyst here at BofA. And I'm very excited that we have Rocket Pharma with us today.
Here to speak on behalf of Rocket is President and CEO, Gaurav Shah. And if you'd like to send me questions, you can do so anonymously, and I can read them at the end if we have time.
And with that, I'll hand it over to Gaurav.
Great. Thank you, Greg, for having us today. And I hope that you and everybody on the call is safe and healthy in these challenging times. And this particular conference call comes at a very opportune time, couldn't be better timing actually. We had some updates at ASGCT yesterday and this week. And we also, of course, along with others, had earnings. So it's a great opportunity to update the group on the ongoings at Rocket.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |